2,6,9-trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro

Eva Řezníčková, Alexandr Popa, Tomáš Gucký, Marek Zatloukal, Libor Havlíček, Václav Bazgier, Karel Berka, Radek Jorda, Igor Popa, Abdelmajeed Nasereddin, Charles L. Jaffe, Vladimír Kryštof*, Miroslav Strnad

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Abstract Here we describe the leishmanicidal activities of a library of 2,6,9-trisubstituted purines that were screened for interaction with Cdc2-related protein kinase 3 (CRK3) and subsequently for activity against parasitic Leishmania species. The most active compound inhibited recombinant CRK3 with an IC50 value of 162 nM and was active against Leishmania major and Leishmania donovani at low micromolar concentrations in vitro. Its mode of binding to CRK3 was investigated by molecular docking using a homology model.

Original languageEnglish
Article number22613
Pages (from-to)2298-2301
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume25
Issue number11
DOIs
StatePublished - 1 Jun 2015

Bibliographical note

Publisher Copyright:
© 2015 Elsevier Ltd. All rights reserved.

Keywords

  • Cyclin-dependent kinase
  • Inhibitor
  • Leishmania
  • Purine

Fingerprint

Dive into the research topics of '2,6,9-trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro'. Together they form a unique fingerprint.

Cite this